Upregulation of oncostatin M in allergic rhinitis

Hee Joon Kang, Jae Seong Kang, Sang Hag Lee, Soon Jae Hwang, Sungwon Chae, Jeong-Soo Woo, Heung Man Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

OBJECTIVES: Oncostatin M is a multifunctional cytokine belonging to the interleukin-6 family of cytokines. It has been implicated as an important modulator of lower airway remodeling in the setting of asthma. However, there have been few studies regarding a similar role for the upper airway epithelium in the setting of allergic rhinitis. This study was undertaken to investigate the expression of oncostatin M mRNA and protein in normal and allergic rhinitis nasal mucosa and to localize the expression of the oncostatin M protein in allergic rhinitis. MATERIALS AND METHODS: Inferior turbinate mucosa samples from 20 patients with perennial allergic rhinitis and 20 matched normal control subjects were obtained. Oncostatin M mRNA was extracted from the inferior turbinate mucosae, then reverse transcriptase-polymerase chain reaction was performed and analyzed semiquantitatively. Differences in expression levels of oncostatin M protein between samples from allergic rhinitis patients and normal control subjects were analyzed through Western blot, and oncostatin M protein was localized immunohistochemically. RESULTS: The expression levels of oncostatin M mRNA and protein were significantly upregulated in patients with allergic rhinitis mucosa. Oncostatin M protein was predominantly localized in the surface epithelium, infiltrating inflammatory cells, vascular endothelium, and submucosal glands and was more strongly expressed in the nasal mucosa of patients with allergic rhinitis than in normal control subjects. CONCLUSIONS: Oncostatin M is expressed in the human nasal mucosa and is upregulated in the setting of allergic nasal inflammation. These results suggest a possible contribution of oncostatin M in the remodeling of the nasal mucosa in allergic rhinitis.

Original languageEnglish
Pages (from-to)2213-2216
Number of pages4
JournalLaryngoscope
Volume115
Issue number12
DOIs
Publication statusPublished - 2005 Dec 1

Fingerprint

Oncostatin M
Up-Regulation
Nasal Mucosa
Turbinates
Mucous Membrane
Proteins
Messenger RNA
Epithelium
Rhinitis, Allergic, Perennial
Allergic Rhinitis
Cytokines
Airway Remodeling
Vascular Endothelium
Reverse Transcriptase Polymerase Chain Reaction
Nose
Interleukin-6
Asthma
Western Blotting

Keywords

  • Allergic rhinitis
  • Oncostatin M
  • Remodeling

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Upregulation of oncostatin M in allergic rhinitis. / Kang, Hee Joon; Kang, Jae Seong; Lee, Sang Hag; Hwang, Soon Jae; Chae, Sungwon; Woo, Jeong-Soo; Lee, Heung Man.

In: Laryngoscope, Vol. 115, No. 12, 01.12.2005, p. 2213-2216.

Research output: Contribution to journalArticle

Kang, Hee Joon ; Kang, Jae Seong ; Lee, Sang Hag ; Hwang, Soon Jae ; Chae, Sungwon ; Woo, Jeong-Soo ; Lee, Heung Man. / Upregulation of oncostatin M in allergic rhinitis. In: Laryngoscope. 2005 ; Vol. 115, No. 12. pp. 2213-2216.
@article{784cf21a824044d5b0613667cee7f68a,
title = "Upregulation of oncostatin M in allergic rhinitis",
abstract = "OBJECTIVES: Oncostatin M is a multifunctional cytokine belonging to the interleukin-6 family of cytokines. It has been implicated as an important modulator of lower airway remodeling in the setting of asthma. However, there have been few studies regarding a similar role for the upper airway epithelium in the setting of allergic rhinitis. This study was undertaken to investigate the expression of oncostatin M mRNA and protein in normal and allergic rhinitis nasal mucosa and to localize the expression of the oncostatin M protein in allergic rhinitis. MATERIALS AND METHODS: Inferior turbinate mucosa samples from 20 patients with perennial allergic rhinitis and 20 matched normal control subjects were obtained. Oncostatin M mRNA was extracted from the inferior turbinate mucosae, then reverse transcriptase-polymerase chain reaction was performed and analyzed semiquantitatively. Differences in expression levels of oncostatin M protein between samples from allergic rhinitis patients and normal control subjects were analyzed through Western blot, and oncostatin M protein was localized immunohistochemically. RESULTS: The expression levels of oncostatin M mRNA and protein were significantly upregulated in patients with allergic rhinitis mucosa. Oncostatin M protein was predominantly localized in the surface epithelium, infiltrating inflammatory cells, vascular endothelium, and submucosal glands and was more strongly expressed in the nasal mucosa of patients with allergic rhinitis than in normal control subjects. CONCLUSIONS: Oncostatin M is expressed in the human nasal mucosa and is upregulated in the setting of allergic nasal inflammation. These results suggest a possible contribution of oncostatin M in the remodeling of the nasal mucosa in allergic rhinitis.",
keywords = "Allergic rhinitis, Oncostatin M, Remodeling",
author = "Kang, {Hee Joon} and Kang, {Jae Seong} and Lee, {Sang Hag} and Hwang, {Soon Jae} and Sungwon Chae and Jeong-Soo Woo and Lee, {Heung Man}",
year = "2005",
month = "12",
day = "1",
doi = "10.1097/01.mlg.0000187819.89889.4a",
language = "English",
volume = "115",
pages = "2213--2216",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Upregulation of oncostatin M in allergic rhinitis

AU - Kang, Hee Joon

AU - Kang, Jae Seong

AU - Lee, Sang Hag

AU - Hwang, Soon Jae

AU - Chae, Sungwon

AU - Woo, Jeong-Soo

AU - Lee, Heung Man

PY - 2005/12/1

Y1 - 2005/12/1

N2 - OBJECTIVES: Oncostatin M is a multifunctional cytokine belonging to the interleukin-6 family of cytokines. It has been implicated as an important modulator of lower airway remodeling in the setting of asthma. However, there have been few studies regarding a similar role for the upper airway epithelium in the setting of allergic rhinitis. This study was undertaken to investigate the expression of oncostatin M mRNA and protein in normal and allergic rhinitis nasal mucosa and to localize the expression of the oncostatin M protein in allergic rhinitis. MATERIALS AND METHODS: Inferior turbinate mucosa samples from 20 patients with perennial allergic rhinitis and 20 matched normal control subjects were obtained. Oncostatin M mRNA was extracted from the inferior turbinate mucosae, then reverse transcriptase-polymerase chain reaction was performed and analyzed semiquantitatively. Differences in expression levels of oncostatin M protein between samples from allergic rhinitis patients and normal control subjects were analyzed through Western blot, and oncostatin M protein was localized immunohistochemically. RESULTS: The expression levels of oncostatin M mRNA and protein were significantly upregulated in patients with allergic rhinitis mucosa. Oncostatin M protein was predominantly localized in the surface epithelium, infiltrating inflammatory cells, vascular endothelium, and submucosal glands and was more strongly expressed in the nasal mucosa of patients with allergic rhinitis than in normal control subjects. CONCLUSIONS: Oncostatin M is expressed in the human nasal mucosa and is upregulated in the setting of allergic nasal inflammation. These results suggest a possible contribution of oncostatin M in the remodeling of the nasal mucosa in allergic rhinitis.

AB - OBJECTIVES: Oncostatin M is a multifunctional cytokine belonging to the interleukin-6 family of cytokines. It has been implicated as an important modulator of lower airway remodeling in the setting of asthma. However, there have been few studies regarding a similar role for the upper airway epithelium in the setting of allergic rhinitis. This study was undertaken to investigate the expression of oncostatin M mRNA and protein in normal and allergic rhinitis nasal mucosa and to localize the expression of the oncostatin M protein in allergic rhinitis. MATERIALS AND METHODS: Inferior turbinate mucosa samples from 20 patients with perennial allergic rhinitis and 20 matched normal control subjects were obtained. Oncostatin M mRNA was extracted from the inferior turbinate mucosae, then reverse transcriptase-polymerase chain reaction was performed and analyzed semiquantitatively. Differences in expression levels of oncostatin M protein between samples from allergic rhinitis patients and normal control subjects were analyzed through Western blot, and oncostatin M protein was localized immunohistochemically. RESULTS: The expression levels of oncostatin M mRNA and protein were significantly upregulated in patients with allergic rhinitis mucosa. Oncostatin M protein was predominantly localized in the surface epithelium, infiltrating inflammatory cells, vascular endothelium, and submucosal glands and was more strongly expressed in the nasal mucosa of patients with allergic rhinitis than in normal control subjects. CONCLUSIONS: Oncostatin M is expressed in the human nasal mucosa and is upregulated in the setting of allergic nasal inflammation. These results suggest a possible contribution of oncostatin M in the remodeling of the nasal mucosa in allergic rhinitis.

KW - Allergic rhinitis

KW - Oncostatin M

KW - Remodeling

UR - http://www.scopus.com/inward/record.url?scp=33644805845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644805845&partnerID=8YFLogxK

U2 - 10.1097/01.mlg.0000187819.89889.4a

DO - 10.1097/01.mlg.0000187819.89889.4a

M3 - Article

VL - 115

SP - 2213

EP - 2216

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 12

ER -